EPISODE · Mar 23, 2022 · 38 MIN
A Deep Dive into Myelofibrosis
Srdan Verstovsek, MD, PhD, MD Anderson Cancer Center, Houston, TX Recorded on February 18, 2022 Srdan Verstovsek, MD, PhD Professor of Medicine Director, Hanns A. Pielenz Clinical Research Center for Myeloproliferative Neoplasms Department of Leukemia MD Anderson Cancer Center Houston, TX In this month’s episode, Dr. Srdan Verstovsek, from MD Anderson Cancer Center in Houston, Texas, joins us to discuss myelofibrosis. What is myelofibrosis? What is our understanding of the disease? What are the deciding factors for cells to branch off into myelofibrosis and not other myeloproliferative neoplasms? Tune in as we explore myelofibrosis, including discussion on diagnosing and staging, goals and considerations for therapy, the impact of COVID-19 on treatment, and new and emerging drugs in development. This podcast episode is supported by AbbVie Inc.
NOW PLAYING
A Deep Dive into Myelofibrosis
No transcript for this episode yet
Similar Episodes
May 4, 2026 ·16m
Apr 27, 2026 ·17m
Apr 13, 2026 ·16m
Apr 6, 2026 ·16m
Mar 30, 2026 ·16m
Mar 23, 2026 ·17m